FDA Approved: SUBLOCADE — Original Application (Indivior Inc.)

View source ↗

Summary

FDA approved SUBLOCADE, a long-acting injectable buprenorphine, under the original application for the treatment of opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

ORIG AP for SUBLOCADE (BUPRENORPHINE)